Has Katherine Placido received payments from drug or device companies?

Yes. Drug and device makers reported $8,923 in general payments to Katherine Placido across 461 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Katherine Placido did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Katherine Placido come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Katherine Placido

Physician Assistant · Farmington Hills, MINPI 1619201563

Payments from drug & device makers

$8,923in general payments, 2019–2025

Across 461 payments — averaging $19.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Amgen$2K
AbbVie$2K
Johnson & Johnson$810
Lilly USA, LLC$800
Pfizer$672
UCB, Inc.$634
plus $2K from 22 others

What the payments were for

Food & beverage$8,86899%
Education$551%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Amgen(2 entities)	100	$1,928
AbbVie	110	$1,911
Johnson & Johnson	37	$810
Lilly USA, LLC	38	$800
Pfizer	43	$672
UCB, Inc.	24	$634
Novartis	28	$434
ANI Pharmaceuticals, Inc.	14	$254
AstraZeneca(2 entities)	12	$218
E.r. Squibb & Sons, L.L.C.	14	$211
Radius Health, Inc.	8	$194
Mallinckrodt Hospital Products Inc.	6	$156
Fresenius Kabi USA, LLC	4	$105
Aurinia Pharma U.S., Inc.	1	$98
Genentech USA, Inc.	3	$79
Boehringer Ingelheim	2	$55
Kyowa Kirin, Inc.	2	$54
GSK	2	$39
Sanofi	2	$39
Sandoz	2	$34
Almatica Pharma LLC	2	$32
Sobi, Inc	1	$32
Pharming Healthcare, Inc.	1	$31
Organon	1	$29
Boston Scientific	1	$21
Nevro Corp.	1	$20
Abbott	1	$17
Octapharma USA, Inc.	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

KRYSTEXXA$125
TALTZ$125
Otezla$116
Prolia$100

How this compares

$8,923 in reported general payments places this provider in the 95th percentile of 5,453 physician assistant providers in Michigan.

See all physician assistant providers in Michigan →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Cosentyx (2 Syringes)Secukinumab	17	$146,281
EnbrelEtanercept	13	$99,374
OtezlaApremilast	18	$91,141
Humira(Cf) PenAdalimumab	11	$75,060
Hydroxychloroquine Sulfate	305	$10,961
MethotrexateMethotrexate Sodium	302	$7,084
Diclofenac Sodium	61	$3,859
Duloxetine Hcl	179	$3,063
Mycophenolate Mofetil	61	$2,985
Leflunomide	49	$1,785
Prednisone	209	$1,513
Sulfasalazine DrSulfasalazine	58	$1,437
Celecoxib	59	$1,214
Colchicine	32	$1,186
Sulfasalazine	40	$948

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
AmgenEnbrel, Otezla	$1,928	$190,51531 claims
NovartisCosentyx (2 Syringes)	$434	$146,28117 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 5,453 physician assistant providers in Michigan.

Other physician assistant in Farmington Hills

Sarang PatelRoyal Oak$660K
Beth SweneyAda$617K
Zainab JishiCanton$596K
Taylor HennrickAdrian$430K
Erin van DykeGrand Rapids$346K
Ashley AldridgeAnn Arbor$298K
Derek SusallaRochester Hills$242K
Gabrielle DamoreRoyal Oak$200K
Melissa MickelsonKalamazoo$168K
Patrick CooneyNew Baltimore$91K

See the full list for Michigan →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →